Stay updated on Bispecific Antibody MCLA-158 Clinical Trial
Sign up to get notified when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.

Latest updates to the Bispecific Antibody MCLA-158 Clinical Trial page
- Check6 days agoChange DetectedNew navigation/help sections such as Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study were added, improving access to participation and information. The Intervention/Treatment heading formatting was updated (from 'Intervention / Treatment' to 'Intervention/Treatment'), and the footer revision label now shows Revision: v3.6.0, replacing the previous v3.5.5.SummaryDifference0.2%

- Check13 days agoChange DetectedThe page shows a new revision label, updating from v3.5.4 to v3.5.5. This indicates a new version of the page with minor edits or fixes.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays Revision: v3.5.4 instead of v3.5.3, indicating a small release update to the page template.SummaryDifference0.0%

- Check56 days agoChange DetectedThe page will now display an updated ClinicalTrials.gov release/version identifier (Revision v3.5.3 instead of v3.5.2). This reflects a technical site revision rather than a change to the underlying study details.SummaryDifference0.0%

- Check63 days agoChange DetectedRevision updated to v3.5.2 and the previous v3.5.0 revision was removed.SummaryDifference0.0%

- Check85 days agoChange DetectedAdded 'Squamous cell carcinoma of the head and neck' to the study's conditions.SummaryDifference0.0%

Stay in the know with updates to Bispecific Antibody MCLA-158 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bispecific Antibody MCLA-158 Clinical Trial page.